New imaging study tracks Cancer's sneaky resistance in real time
NCT ID NCT07302763
First seen Jan 04, 2026 · Last updated May 06, 2026 · Updated 18 times
Summary
This study aims to understand why some prostate cancer tumors stop responding to treatment while others shrink. Researchers will use special PET scans to measure cancer activity in each tumor before, during, and after therapy in 45 men with advanced prostate cancer. The goal is to identify patterns of resistance and guide better treatment decisions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MCRPC (METASTATIC CASTRATION-RESISTANT PROSTATE CANCER) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU de Québec-Université Laval
RECRUITINGQuébec, Quebec, G1J1Z4, Canada
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.